Journal
EXPERT REVIEW OF VACCINES
Volume 15, Issue 3, Pages 389-399Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14760584.2016.1125785
Keywords
vaccine; pre-erythrocytic; cross-reactivity; Malaria; immune interference; immune evasion; antigen; polymorphism; antagonism
Categories
Funding
- Australian Postgraduate Award (APA) scholarship
Ask authors/readers for more resources
The pre-erythrocytic stage of infection by malaria parasites represents a key target for vaccines that aim to eradicate malaria. Two important broad immune evasion strategies that can interfere with vaccine efficacy include the induction of dendritic cell (DC) dysfunction and regulatory T cells (Tregs) by blood-stage malaria parasites, leading to inefficient priming of T cells targeting liver-stage infections. The parasite also uses 'surgical strike' strategies, whereby polymorphism in pre-erythrocytic antigens can interfere with host immunity. Specifically, we review how even single amino acid changes in T cell epitopes can lead to loss of binding to major histocompatibility complex (MHC), lack of cross-reactivity, or antagonism and immune interference, where simultaneous or sequential stimulation with related variants of the same T cell epitope can cause T cell anergy or the conversion of effector to immunosuppressive T cell phenotypes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available